BIT 0.00% 2.2¢ biotron limited

a cure for hep c, aids, the flu and dengue..., page-62

  1. 1,843 Posts.
    G'day, just a little read on the enormous unmet need for an effective Dengue medicine. The article discusses the ongoing attempts to exploit the protease-inhibitors used in existing HCV treatments for use against Dengue, an expected billion dollar market.

    BIT225 is in preclinical studies to determine efficacy against Dengue.

    The link is as follows:

    http://www.bloomberg.com/news/2010-10-26/break-bone-fever-draws-roche-drug-as-dengue-virus-hits-riviera.html

    Cheers
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.